News >

MCL Armamentarium Expands, But Quest Continues for Curative Approaches

Kristi Rosa
Published: Wednesday, Apr 17, 2019

Ann S. LaCasce, MD, MMSc

Ann S. LaCasce, MD, MMSc

The field of mantle cell lymphoma (MCL) has progressed considerably in recent years with the emergence of several practice-changing agents that have led to significant increases in survival, said Ann S. LaCasce, MD, MMSc. Now, investigators are shifting their focus to CAR T-cell therapy in the hunt for a curative approach.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Archived Version of a Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of CAR T-Cell Therapy in Hematologic MalignanciesJun 29, 20192.0
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Publication Bottom Border
Border Publication
x